“There has been an absolute paradigm shift in the treatment of lung cancer in the last year”
The European Society for Thoracic Surgery (ESTS) has just named the Dr. Nuria Novoahead of…
0 Comments
‘Impressive’ progression-free survival with lorlatinib in non-small cell lung cancer
CHICAGO, USA. The benefit seen with lorlatinib in the 5-year follow-up data from the CROWN…
0 Comments
Lorlatinib Follow-up Data Show Prolonged Progression-Free Survival in ALK-Positive Advanced Lung Cancer
Pfizer today announced long-term follow-up results from the CROWN study7.8Phase III trial evaluating lorlatinib (▼Lorviqua®),…
0 Comments
60% of patients with advanced lung cancer live more than 5 years without disease progression
New research released in recent days indicates that 60% of patients with ALK-positive advanced lung…
0 Comments
A new era of drugs manages to penetrate the most aggressive lung cancer | Health & Wellness
There is a lung cancer that grows furiously, very quickly and very aggressively. It is…
0 Comments
A new era of drugs manages to penetrate the most aggressive lung cancer | Health & Wellness
There is a lung cancer that grows furiously, very quickly and very aggressively. It is…
0 Comments
Lung cancer screening identifies pulmonary comorbidities
Lung cancer screening with low-dose computed tomography (LDCT) can effectively screen a population at high…
0 Comments
Drinking alcohol on flight: how it impacts heart and lung health
Hypobaric hypoxia can affect the passenger's physiology (Freepik)In the routine of a long distance flight,…
0 Comments
New advances in ASCO from Johnson&Johnson for lung cancer
Johnson & Johnson has announced the submission of an application for extension of the marketing…
0 Comments
VAPING ALICANTE | Teens who vape are at risk of lung cancer by age 30
The new products from tobacco and vaping are gaining ground among adolescents from 12 to…
0 Comments